文献速递乳房整形与再造

基于证据的脱细胞真皮基质在即刻扩张器-假体乳房再造中的应用

Development of an evidence-based approach to the use of acellular dermal matrix in immediate expander-implant-based breast reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-10-21

本研究基于前瞻性多中心队列,评估1451例即刻扩张器-假体乳房再造患者使用脱细胞真皮基质(ADM)的并发症与患者报告结局。结果显示ADM使用者主要并发症风险更高(22.9% vs 16.4%,P=0.04),且随BMI升高而增加(BMI=30时OR=1.70,BMI=35时OR=2.29,交互P=0.02);未发现ADM在任何亚组中改善患者报告结局。

要点

  • ADM使用与主要并发症风险升高相关(22.9% vs 16.4%,P=0.04)。
  • 高BMI患者使用ADM的主要并发症风险进一步增加(交互P=0.02)。
  • 未发现ADM在任一亚组中显著改善患者报告结局。

核心结论

  • 在即刻扩张器-假体乳房再造中,ADM与主要并发症风险增加相关,尤其在高BMI患者中。
  • 未能识别出ADM与患者报告结局显著改善相关的患者亚组。

研究设计与样本

  • 乳房切除重建结局联盟研究前瞻性评估2012至2015年间11个中心的即刻扩张器-假体乳房再造。
  • 共纳入1451例患者,其中738例使用ADM,713例未使用。

主要发现

  • ADM使用者主要并发症风险高于非使用者(22.9% vs 16.4%,P=0.04)。
  • ADM使用者的主要并发症风险随BMI升高而增加(BMI=30时OR=1.70,BMI=35时OR=2.29,交互P=0.02)。
  • 在各亚组中,ADM对乳房满意度、心理社会、性及身体健康状况均无显著影响。

临床怎么用

  • 在高BMI患者中应更审慎地使用ADM。
  • 考虑ADM费用,应基于证据选择性使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although acellular dermal matrix (ADM) is widely used in expander-implant-based breast reconstructions, previous analyses have been unable to demonstrate improvements in patient-reported outcomes (PROs) with this approach over non-ADM procedures. This study aims to develop a more selective, evidence-based approach to the use of ADM in expander-implant-based breast reconstruction by identifying patient subgroups in which ADM improved clinical outcomes and PROs. STUDY DESIGN: The Mastectomy Reconstruction Outcomes Consortium Study prospectively evaluated immediate expander-implant reconstructions at 11 centers from 2012 to 2015. Complications (any/overall and major), and PROs (satisfaction, physical, psychosocial, and sexual well-being) were assessed two years postoperatively using medical records and the BREAST-Q, respectively. Using mixed-models accounting for centers and with interaction terms, we analyzed for differential ADM effects across various clinical subgroups, including age, body mass index, radiation timing, and chemotherapy. RESULTS: Expander-implant-based breast reconstruction was performed in 1451 patients, 738 with and 713 without ADM. Major complication risk was higher in ADM users vs. nonusers (22.9% vs. 16.4% and p = 0.04). Major complication risk with ADM increased with higher BMI (BMI=30, OR=1.70; BMI=35, OR=2.29, interaction p = 0.02). No significant ADM effects were observed for breast satisfaction, psychosocial, sexual, and physical well-being within any subgroups. CONCLUSION: In immediate expander-implant-based breast reconstruction, ADM was associated with a greater risk of major complications, particularly in high-BMI patients. We were unable to identify patient subgroups where ADM was associated with significant improvements in PROs. Given these findings and the financial costs of ADM, a more critical approach to the use of ADM in expander-implant reconstruction may be warranted.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Ganesh Kumar N, Berlin NL, Kim HM, et al. Development of an evidence-based approach to the use of acellular dermal matrix in immediate expander-implant-based breast reconstruction. J Plast Reconstr Aesthet Surg. 2020. PMID: 33172826. doi:10.1016/j.bjps.2020.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。